Get the Stockscreener App
14.90
10.29%
1.39
After Hours:
14.77
-0.13
-0.87%
Cargo Therapeutics Inc stock is traded at $14.90, with a volume of 1.01M.
It is up +10.29% in the last 24 hours and down -5.82% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$13.51
Open:
$13.34
24h Volume:
1.01M
Relative Volume:
3.67
Market Cap:
$685.81M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-127.89M
1W Performance:
+8.44%
1M Performance:
-5.82%
6M Performance:
-0.93%
1Y Performance:
-19.98%
1-Day Range:
$12.72
$15.01
1-Week Range:
$12.17
$15.26
52-Week Range:
$12.17
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
14.90 | 685.81M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 5.4%Here's Why - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Reaches New 1-Year LowHere's What Happened - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.1%Time to Sell? - MarketBeat
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
CARGO Therapeutics to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Corcept Therapeutics’ Cushing’s syndrome therapy shows promise in Phase III trial - Yahoo Finance
GSK’s lung cancer therapy gains EMA PRIME designation - Yahoo Finance
BNP Paribas Financial Markets Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Australian consumers fret over the economy in December, survey shows - Yahoo Finance
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround - Yahoo Finance
Becton Dickinson to Pay $175 Million to Settle SEC Probe - Yahoo Finance
CARGO Therapeutics (NASDAQ:CRGX) Hits New 1-Year LowHere's Why - MarketBeat
Bears are Losing Control Over CARGO Therapeutics, Inc. (CRGX), Here's Why It's a 'Buy' Now - MSN
CARGO Therapeutics stock hits 52-week low at $13.49 By Investing.com - Investing.com UK
Wellington Management Group LLP Increases Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Clear Street sets Cargo Therapeutics at Buy with $28 target By Investing.com - Investing.com UK
Alaska Air cargo profits set to blossom with international expansion - Yahoo Finance
Keros shares collapse on ‘unanticipated’ setback for lung disease drug - Yahoo Finance
Clear Street sets Cargo Therapeutics at Buy with $28 target - Investing.com
Alphabet stock pops on Google's new quantum chip - Yahoo Finance
When the Price of (CRGX) Talks, People Listen - Stock Traders Daily
Townsquare Capital LLC Buys New Shares in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
MetLife Investment Management LLC Grows Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Up 8.7%What's Next? - MarketBeat
Janus Henderson Group PLC Purchases 46,659 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $31.80 Consensus Target Price from Analysts - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Average Recommendation of “Buy” by Brokerages - Defense World
Fmr LLC Increases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Earns Outperform Rating from Analysts at William Blair - Defense World
173,860 Shares in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Acquired by Sio Capital Management LLC - MarketBeat
Equities Analysts Set Expectations for CRGX FY2024 Earnings - Defense World
FY2024 Earnings Estimate for CRGX Issued By William Blair - MarketBeat
Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation - Simply Wall St
Analyzing JATT Acquisition (NYSE:JATT) and CARGO Therapeutics (NASDAQ:CRGX) - Defense World
Five new option listings on November 27th - TipRanks
William Blair Initiates Coverage of CARGO Therapeutics (CRGX) with Outperform Recommendation - MSN
Cargo Therapeutics draws bullish view at William Blair on lead asset - MSN
Cargo Therapeutics stock wins over William Blair - Seeking Alpha
CARGO Therapeutics (NASDAQ:CRGX) Now Covered by Analysts at William Blair - MarketBeat
Alexandria Inks 259 KSF Bay Area Life Science Lease - Commercial Property Executive
Companies get creative with multi-targeted CARs at SITC, ASH - BioCentury
Long Term Trading Analysis for (CRGX) - Stock Traders Daily
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from Chardan Capital - Defense World
Janus Henderson Group PLC's Strategic Acquisition in Cargo Thera - GuruFocus.com
RTW INVESTMENTS, LP Expands Stake in Cargo Therapeutics Inc - GuruFocus.com
CARGO Therapeutics Advances in Cancer Therapy Development - TipRanks
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Reviewing CARGO Therapeutics (CRGX) & The Competition - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of “Buy” from Analysts - Defense World
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):